Bone marrow cell transplantation in clinical perspective.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2005-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.YJMCC.2004.12.005PMID 15698828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

  2004cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Hematopoietic stem cells and endothelial cell precursors express Tie-2, CD31 and CD45.

  2004cited by this paper
• Autotransplantation of Unmanipulated Bone Marrow into Scarred Myocardium is Safe and Enhances Cardiac Function in Humans

  2004cited by this paper
• Stable benefit of embryonic stem cell therapy in myocardial infarction.

  2004cited by this paper
• Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro

  2004cited by this paper
• Human Mesenchymal Stem Cells Form Purkinje Fibers in Fetal Sheep Heart

  2004cited by this paper
• Stem cell transplantation for myocardial infarction?

  2004cited by this paper
• Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy.

  2004cited by this paper
• Combine autologous myoblast intramyocardial injection with coronary revascularization in patients with non-acute myocardial infarction

  2004cited by this paper
• Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

  2004cited by this paper
• [Intracoronary stem cell transplantation in acute myocardial infarction].

  2004cited by this paper
• Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

  2004cited by this paper
• Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

  2004cited by this paper
• Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

  2004cited by this paper
• Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.

  2004cited by this paper
• Experimental and Clinical Regenerative Capability of Human Bone Marrow Cells After Myocardial Infarction

  2004cited by this paper
• CABG and bone marrow stem cell transplantation after myocardial infarction.

  2004cited by this paper
• Understanding cell lineages as complex adaptive systems.

  2004cited by this paper
• Autologous Bone Marrow Cell Transplantation Combined with Off-Pump Coronary Artery Bypass Grafting in Human Ischemic Myocardium

  2004cited by this paper
• Stem cell plasticity or fusion: two approaches to targeted cell therapy.

  2004cited by this paper
• Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium.

  2004cited by this paper
• Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease

  2004cited by this paper
• Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells.

  2004cited by this paper
• Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease.

  2004cited by this paper
• Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes

  2004cited by this paper
• Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomized clinical trial

  2004cited by this paper
• Differentiation of Bone Marrow Stromal Cells Into the Cardiac Phenotype Requires Intercellular Communication With Myocytes

  2004cited by this paper
• Cardiac chimerism in recipients of peripheral‐blood and bone marrow stem cells

  2004cited by this paper
• Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction

  2004cited by this paper
• Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapy.

  2004cited by this paper
• Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium.

  2004cited by this paper
• G-CSF treatment increases side population cell infiltration after myocardial infarction in mice.

  2004cited by this paper
• Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor

  2004cited by this paper
• Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor

  2004cited by this paper
• Cellular myocardial reconstruction using human myoblasts.

  2003cited by this paper
• Treatment of acute myocardial infarction: better, but still not good enough.

  2003cited by this paper
• Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.

  2003cited by this paper
• Systemic Delivery of Bone Marrow–Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution

  2003cited by this paper
• Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study.

  2003cited by this paper
• Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor.

  2003cited by this paper
• Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy.

  2003cited by this paper
• Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium.

  2003cited by this paper
• Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

  2003cited by this paper
• [Mobilization of bone marrow stem cells in the management of patients with heart failure. Protocol and first results of ROT FRONT trial].

  2003cited by this paper
• Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT)

  2003cited by this paper
• Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction.

  2003cited by this paper
• Improvement in global and segmental left ventricular contractility following autologous bone marrow cell transplantation in humans with severe ischemic heart failure

  2003cited by this paper
• Cardiac cell transplantation: closer to bedside.

  2003cited by this paper
• Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia

  2003cited by this paper
• Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

  2003cited by this paper
• Mesenchymal Progenitor Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Rat Cellular Cardiomyoplasty Model

  2003cited by this paper
• Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo

  2003cited by this paper
• Mobilization and homing of bone marrow stromal cells in myocardial infarction.

  2003cited by this paper
• Bone marrow-derived stem cells and "plasticity"

  2003cited by this paper
• 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction

  2003cited by this paper
• Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

  2003cited by this paper
• Transplantation of cells for cardiac repair.

  2003cited by this paper
• Autologous bone marrow stem cell transplantation in acute myocardial infarction-report of two cases.

  2003cited by this paper
• Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model.

  2003cited by this paper
• Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair.

  2003cited by this paper
• Adult cardiac stem cells are multipotent and support myocardial regeneration.

  2003cited by this paper
• Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart.

  2003cited by this paper
• Transplantation of Autologous Fresh Bone Marrow Into Infarcted Myocardium: A Word of Caution

  2003cited by this paper
• Plasticity of marrow-derived stem cells.

  2003cited by this paper
• CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation.

  2003cited by this paper
• Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure

  2003cited by this paper
• Myocyte and myogenic stem cell transplantation in the heart.

  2003cited by this paper
• Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging

  2003cited by this paper
• Evidence for transdifferentiation of human bone marrow‐derived stem cells: recent progress and controversies

  2003cited by this paper
• Improved myocardial viability following intramyocardial autologous bone marrow injection after acute myocardial infarction

  2003cited by this paper
• In vitro preprogramming of marrow stromal cells for myocardial regeneration.

  2002cited by this paper
• Differentiation plasticity of hematopoietic cells.

  2002cited by this paper
• Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart

  2002cited by this paper
• Myocyte renewal and ventricular remodelling

  2002cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

  2002cited by this paper
• Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis.

  2002cited by this paper
• VEGF gene delivery for treatment of ischemic cardiovascular disease.

  2002cited by this paper
• Chimerism of the transplanted heart.

  2002cited by this paper
• Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs.

  2002cited by this paper
• Reprogramming of bone marrow mesenchymal stem cells into cardiomyocytes.

  2002cited by this paper
• Therapeutic angiogenesis induced by local autologous bone marrow cell implantation.

  2002cited by this paper
• Changing potency by spontaneous fusion

  2002cited by this paper
• Myocyte growth and cardiac repair.

  2002cited by this paper
• Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation.

  2002cited by this paper
• Enhanced Myocardial Angiogenesis by Gene Transfer With Transplanted Cells

  2001cited by this paper
• Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study

  2001cited by this paper
• Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results.

  2001cited by this paper
• Cardiomyocyte death and heart failure

  2001cited by this paper
• Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction

  2001cited by this paper
• Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

  2001cited by this paper
• Bone Marrow as a Source of Endothelial Cells for Natural and Iatrogenic Vascular Repair

  2001cited by this paper
• Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia

  2001cited by this paper
• Myoblast transplantation for heart failure.

  2001cited by this paper
• Helping the heart to heal with stem cells

  2001cited by this paper
• Therapeutic angiogenesis for ischemic cardiovascular disease.

  2001cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper
• Cellular therapy reverses myocardial dysfunction.

  2001cited by this paper
• Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

  2001cited by this paper

• Sources and Therapeutic Strategies of Mesenchymal Stem Cells in Regenerative Medicine

  2022cites this paper
• Advances, Opportunities, and Challenges in Stem Cell-Based Therapy

  2022cites this paper
• Mesenchymal Stem Cell-Based Heart Cell Therapy: The Effect of Route of Cell Delivery in the Clinical Perspective

  2021cites this paper
• Intravenous Administration of Heat Shock-Treated MSCs Can Improve Neuroprotection and Neuroregeneration in Canine Spinal Cord Injury Model

  2020cites this paper
• Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy

  2019cites this paper
• Viability of bone marrow mesenchymal stem cells in inflammation‐induced ischemia‐reperfusion environment

  2018cites this paper
• Bone marrow cell therapy and cardiac reparability: better cell characterization will enhance clinical success.

  2018cites this paper
• Akt—mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity following Embryonic Stem Cell Transplantation

  2015influential citation
• Embryonic Stem Cells and Released Factors Stimulate c-kit+/FLK-1+ Progenitor Cells and Promote Neovascularization in Doxorubicin-Induced Cardiomyopathy

  2015cites this paper
• Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart.

  2013cites this paper
• Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy Mediated through Multiple Mechanisms

  2012cites this paper
• Role of heat shock proteins in stem cell behavior.

  2012cites this paper
• Preconditioning approach in stem cell therapy for the treatment of infarcted heart.

  2012cites this paper
• Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice.

  2011cites this paper
• Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium.

  2011cites this paper
• TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium.

  2011cites this paper
• Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.

  2011cites this paper
• Human embryonic stem cell–derived cardiomyocytes can mobilize 1,4,5‐inositol trisphosphate–operated [Ca2+]i stores

  2010cites this paper
• Bone Marrow‐Derived Cells Implanted into Freeze‐Injured Urinary Bladders Reconstruct Functional Smooth Muscle Layers

  2010cites this paper
• Stem Cells in the Infarcted Heart

  2010influential citation
• Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1+ve Progenitor Cells and Enhance Neovascularization

  2010cites this paper
• ANGIOPOIETIN-1 IN THE TREATMENT OF ISCHEMIA AND SEPSIS

  2009cites this paper
• Are neonatal stem cells as effective as adult stem cells in providing ischemic protection?

  2009cites this paper
• Embryonic Stem Cells in Cardiac Repair and Regeneration

  2009cites this paper
• The Microenvironment of Freeze-Injured Mouse Urinary Bladders Enables Successful Tissue Engineering

  2009cites this paper
• Present Status and Perspectives of Stem Cell-Based Therapies for Gastrointestinal Diseases

  2009cites this paper
• Cardiac regenerative medicine 2.0

  2008cites this paper
• TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways.

  2008cites this paper
• Stem cells as a potential future treatment of pediatric intestinal disorders.

  2008cites this paper
• The right heart and its distinct mechanisms of development, function, and failure.

  2008cites this paper
• GENDER DIFFERENCES IN INJURY INDUCED MESENCHYMAL STEM CELL APOPTOSIS, EXPRESSION OF VEGF, TNF, AND IL-6 AND ABROGATION VIA TNFR1 ABLATION

  2008cites this paper
• Implanted Mouse Bone Marrow-Derived Cells Reconstruct Layered Smooth Muscle Structures in Injured Urinary Bladders

  2008cites this paper
• Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts.

  2008cites this paper
• Study of the Potentiality of a Cell Culture Medium of Autologous Blood Serum for Cell Transplantation Therapy for Injured Vocal Folds

  2008cites this paper
• RESEARC HREVIEW Th eRigh tHear tan dIt sDistinc tMechanism so fDevelopment ,Function, an dFailure 1

  2008cites this paper
• VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

  2008cites this paper
• Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.

  2008cites this paper
• TNFR 1 signaling resistance associated with female stem cell cytokine production is independent of TNFR 2-mediated pathways

  2008cites this paper
• Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production.

  2007cites this paper
• Simultaneous concentration of platelets and marrow cells: A simple and useful technique to obtain source cells and growth factors for regenerative medicine

  2007cites this paper
• Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).

  2007cites this paper
• Limited plasticity of mesenchymal stem cells cocultured with adult cardiomyocytes

  2007cites this paper
• Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism.

  2006cites this paper
• Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement.

  2006cites this paper
• Mechanobiological conditioning of stem cells for cartilage tissue engineering

  2006cites this paper
• 1 HUMAN PROGENITOR CELLS FROM BONE MARROW OR ADIPOSE TISSUE PRODUCE VEGF , HGF AND IGF-1 IN RESPONSE TO TNF BY a p 38 MITOGEN ACIVATED PROTEIN KINASE DEPENDENT MECHANISM

  2006cites this paper
• Stem cell transplantation for the treatment of myocardial infarction.

  2005cites this paper